Thomas G. Elliott

Serum Urate Lowering with Allopurinol and Kidney Function in Type 1 Diabetes

Alessandro Doria, Andrzej T. Gałecki, Cathie Spino et al. · New England Journal of Medicine · 2020 · 357 citations · Full text

Medicine, Endocrinology, Pharmacotherapy +17

Prognostic significance of microalbuminuria in insulin-dependent diabetes mellitus: A twenty-three year follow-up study

Jeannie W.C. Messent, Thomas G. Elliott, R.D. Hill et al. · Kidney International · 1992 · 331 citations · Full text

Medicine, Endocrinology, Internal Medicine +12

Efficacy and safety of dapagliflozin in patients with inadequately controlled type 1 diabetes (DEPICT-1): 24 week results from a multicentre, double-blind, phase 3, randomised controlled trial

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · The Lancet Diabetes & Endocrinology · 2017 · 292 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +10

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes (the DEPICT-2 Study): 24-Week Results From a Randomized Controlled Trial

Paresh Dandona, Pieter Gillard, Peter Senior et al. · Diabetes Care · 2018 · 252 citations

Medicine, Pharmacology, Pharmacotherapy +15

Efficacy and Safety of Dapagliflozin in Patients With Inadequately Controlled Type 1 Diabetes: The DEPICT-1 52-Week Study

Paresh Dandona, Chantal Mathieu, Moshe Phillip et al. · Diabetes Care · 2018 · 238 citations

Medicine, Pharmacology, Pharmacotherapy +17